Passage Historical Balance Sheet

PASG Stock

USD 0.50 0.02 4.17%

Trend analysis of Passage Bio balance sheet accounts such as Other Liabilities of 8.4 M, Net Tangible Assets of 166.4 M, Property Plant And Equipment Net of 19.7 M or Accounts Payable of 704.9 K provides information on Passage Bio's total assets, liabilities, and equity, which is the actual value of Passage Bio to its prevalent stockholders. By breaking down trends over time using Passage Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Passage Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Passage Bio is a good buy for the upcoming year.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Passage Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.

About Passage Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Passage Bio at a specified time, usually calculated after every quarter, six months, or one year. Passage Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Passage Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Passage currently owns. An asset can also be divided into two categories, current and non-current.

Passage Bio Balance Sheet Chart

At this time, Passage Bio's Non Current Assets Total are most likely to increase significantly in the upcoming years. The Passage Bio's current Cash And Short Term Investments is estimated to increase to about 135.4 M, while Other Current Liabilities is projected to decrease to roughly 11.5 M.

Total Assets Other Current Liab Total Current Liabilities Other Liab

Add Fundamental

Total Assets

Total assets refers to the total amount of Passage Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Passage Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Passage Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Passage Bio are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Passage Bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Passage Bio current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Passage Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.At this time, Passage Bio's Non Current Assets Total are most likely to increase significantly in the upcoming years. The Passage Bio's current Cash And Short Term Investments is estimated to increase to about 135.4 M, while Other Current Liabilities is projected to decrease to roughly 11.5 M.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	7.7M	11.7M	14.9M	11.5M
Total Assets	243.5M	150.5M	102.4M	97.3M

Other Current Liab Total Assets

Passage Bio balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Net Working Capital	Common Stock	Property Plant Equipment
Total Assets		0.83	0.86	1.0	0.4	0.82	0.55	-0.67	-0.46	0.91	0.77	0.67	0.72	0.38	0.99	0.68	-0.86	0.15	0.75	-0.57	1.0	0.47	0.99	0.99	0.68	0.51
Other Current Liab	0.83		0.98	0.81	0.74	0.96	0.68	-0.37	-0.78	0.77	0.55	0.73	0.38	0.03	0.84	0.84	-0.81	-0.28	0.91	-0.36	0.81	0.76	0.83	0.76	0.9	0.8
Total Current Liabilities	0.86	0.98		0.84	0.78	0.98	0.78	-0.31	-0.81	0.81	0.51	0.82	0.4	0.06	0.86	0.87	-0.8	-0.27	0.94	-0.31	0.84	0.78	0.86	0.78	0.92	0.84
Total Stockholder Equity	1.0	0.81	0.84		0.36	0.79	0.53	-0.71	-0.44	0.89	0.81	0.65	0.76	0.45	0.99	0.68	-0.88	0.15	0.73	-0.63	1.0	0.44	0.99	0.99	0.67	0.49
Other Liab	0.4	0.74	0.78	0.36		0.75	0.89	0.27	-0.95	0.4	-0.01	0.84	-0.05	-0.23	0.4	0.83	-0.43	-0.7	0.86	0.1	0.36	0.91	0.39	0.25	0.88	0.98
Net Tangible Assets	0.82	0.96	0.98	0.79	0.75		0.73	-0.23	-0.77	0.78	0.41	0.75	0.26	-0.08	0.82	0.79	-0.7	-0.19	0.9	-0.2	0.79	0.75	0.81	0.75	0.89	0.79
Property Plant And Equipment Net	0.55	0.68	0.78	0.53	0.89	0.73		0.17	-0.89	0.48	0.06	0.98	0.17	0.04	0.51	0.86	-0.49	-0.53	0.9	-0.04	0.53	0.91	0.49	0.42	0.88	0.91
Net Debt	-0.67	-0.37	-0.31	-0.71	0.27	-0.23	0.17		-0.16	-0.57	-0.95	-0.02	-0.87	-0.64	-0.69	-0.18	0.69	-0.43	-0.15	0.82	-0.71	0.17	-0.7	-0.75	-0.11	0.11
Retained Earnings	-0.46	-0.78	-0.81	-0.44	-0.95	-0.77	-0.89	-0.16		-0.34	-0.11	-0.87	-0.09	0.03	-0.47	-0.92	0.58	0.75	-0.93	0.12	-0.44	-0.94	-0.45	-0.32	-0.95	-0.97
Accounts Payable	0.91	0.77	0.81	0.89	0.4	0.78	0.48	-0.57	-0.34		0.61	0.56	0.52	0.09	0.9	0.51	-0.64	0.28	0.62	-0.27	0.89	0.39	0.9	0.91	0.56	0.47
Cash	0.77	0.55	0.51	0.81	-0.01	0.41	0.06	-0.95	-0.11	0.61		0.26	0.91	0.67	0.81	0.43	-0.87	0.19	0.39	-0.89	0.81	0.06	0.81	0.82	0.35	0.15
Non Current Assets Total	0.67	0.73	0.82	0.65	0.84	0.75	0.98	-0.02	-0.87	0.56	0.26		0.37	0.23	0.63	0.92	-0.64	-0.5	0.93	-0.24	0.65	0.87	0.62	0.55	0.9	0.9
Non Currrent Assets Other	0.72	0.38	0.4	0.76	-0.05	0.26	0.17	-0.87	-0.09	0.52	0.91	0.37		0.88	0.71	0.46	-0.79	0.16	0.37	-0.9	0.76	0.08	0.71	0.75	0.32	0.13
Other Assets	0.38	0.03	0.06	0.45	-0.23	-0.08	0.04	-0.64	0.03	0.09	0.67	0.23	0.88		0.37	0.29	-0.58	0.05	0.15	-0.87	0.45	-0.08	0.37	0.42	0.11	-0.06
Cash And Short Term Investments	0.99	0.84	0.86	0.99	0.4	0.82	0.51	-0.69	-0.47	0.9	0.81	0.63	0.71	0.37		0.67	-0.89	0.13	0.73	-0.6	0.99	0.43	1.0	0.98	0.68	0.52
Common Stock Shares Outstanding	0.68	0.84	0.87	0.68	0.83	0.79	0.86	-0.18	-0.92	0.51	0.43	0.92	0.46	0.29	0.67		-0.8	-0.61	0.97	-0.43	0.68	0.89	0.65	0.56	0.97	0.92
Non Current Liabilities Total	-0.86	-0.81	-0.8	-0.88	-0.43	-0.7	-0.49	0.69	0.58	-0.64	-0.87	-0.64	-0.79	-0.58	-0.89	-0.8		0.2	-0.77	0.82	-0.88	-0.5	-0.88	-0.83	-0.74	-0.57
Other Current Assets	0.15	-0.28	-0.27	0.15	-0.7	-0.19	-0.53	-0.43	0.75	0.28	0.19	-0.5	0.16	0.05	0.13	-0.61	0.2		-0.5	0.01	0.15	-0.69	0.15	0.29	-0.57	-0.69
Other Stockholder Equity	0.75	0.91	0.94	0.73	0.86	0.9	0.9	-0.15	-0.93	0.62	0.39	0.93	0.37	0.15	0.73	0.97	-0.77	-0.5		-0.32	0.73	0.91	0.72	0.64	0.99	0.92
Total Liab	-0.57	-0.36	-0.31	-0.63	0.1	-0.2	-0.04	0.82	0.12	-0.27	-0.89	-0.24	-0.9	-0.87	-0.6	-0.43	0.82	0.01	-0.32		-0.63	-0.05	-0.6	-0.6	-0.29	-0.08
Net Invested Capital	1.0	0.81	0.84	1.0	0.36	0.79	0.53	-0.71	-0.44	0.89	0.81	0.65	0.76	0.45	0.99	0.68	-0.88	0.15	0.73	-0.63		0.44	0.99	0.99	0.67	0.49
Property Plant And Equipment Gross	0.47	0.76	0.78	0.44	0.91	0.75	0.91	0.17	-0.94	0.39	0.06	0.87	0.08	-0.08	0.43	0.89	-0.5	-0.69	0.91	-0.05	0.44		0.41	0.33	0.92	0.93
Total Current Assets	0.99	0.83	0.86	0.99	0.39	0.81	0.49	-0.7	-0.45	0.9	0.81	0.62	0.71	0.37	1.0	0.65	-0.88	0.15	0.72	-0.6	0.99	0.41		0.98	0.66	0.5
Net Working Capital	0.99	0.76	0.78	0.99	0.25	0.75	0.42	-0.75	-0.32	0.91	0.82	0.55	0.75	0.42	0.98	0.56	-0.83	0.29	0.64	-0.6	0.99	0.33	0.98		0.57	0.37
Common Stock	0.68	0.9	0.92	0.67	0.88	0.89	0.88	-0.11	-0.95	0.56	0.35	0.9	0.32	0.11	0.68	0.97	-0.74	-0.57	0.99	-0.29	0.67	0.92	0.66	0.57		0.94
Property Plant Equipment	0.51	0.8	0.84	0.49	0.98	0.79	0.91	0.11	-0.97	0.47	0.15	0.9	0.13	-0.06	0.52	0.92	-0.57	-0.69	0.92	-0.08	0.49	0.93	0.5	0.37	0.94

Click cells to compare fundamentals

Passage Bio Account Relationship Matchups

Passage Bio balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	328.0M	355.1M	243.5M	150.5M	102.4M	97.3M
Other Current Liab	15.9M	20.1M	7.7M	11.7M	14.9M	11.5M
Total Current Liabilities	21.2M	29.5M	18.4M	16.3M	19.4M	17.1M
Total Stockholder Equity	304.7M	318.7M	201.4M	111.3M	61.3M	58.2M
Net Tangible Assets	(56.3M)	304.7M	318.7M	201.4M	231.6M	166.4M
Property Plant And Equipment Net	2.8M	23.8M	42.2M	32.2M	23.1M	19.7M
Net Debt	(135.0M)	(129.0M)	(7.5M)	4.6M	(12.1M)	(12.7M)
Retained Earnings	(170.9M)	(356.3M)	(492.4M)	(594.5M)	(659.2M)	(626.3M)
Accounts Payable	5.3M	9.4M	4.1M	1.3M	742K	704.9K
Cash	135.0M	129.0M	34.6M	21.7M	37.6M	61.9M
Non Current Assets Total	8.0M	30.0M	46.5M	32.6M	23.6M	24.1M
Non Currrent Assets Other	5.2M	6.2M	4.3M	433K	463K	439.9K
Other Assets	2.8M	0.0	4.3M	1.0	0.9	0.86
Cash And Short Term Investments	304.8M	315.8M	189.6M	114.3M	76.8M	135.4M
Common Stock Shares Outstanding	38.6M	53.3M	54.4M	54.7M	60.4M	52.1M
Liabilities And Stockholders Equity	328.0M	355.1M	243.5M	150.5M	102.4M	97.3M
Non Current Liabilities Total	2.1M	6.9M	23.8M	22.9M	21.8M	14.1M
Other Current Assets	12.4M	9.3M	7.4M	3.7M	2.1M	2.0M
Other Stockholder Equity	475.6M	675.3M	694.7M	705.8M	720.5M	550.9M
Total Liab	23.3M	36.4M	42.2M	39.3M	41.2M	36.5M
Net Invested Capital	304.7M	318.7M	201.4M	111.3M	61.3M	58.2M
Property Plant And Equipment Gross	2.8M	23.8M	22.5M	39.4M	32.9M	19.2M
Total Current Assets	317.2M	325.1M	197.0M	118.0M	78.8M	141.2M
Net Working Capital	296.0M	295.6M	178.7M	101.6M	59.5M	56.5M
Property Plant Equipment	1.1M	2.8M	23.8M	22.5M	25.9M	27.2M
Accumulated Other Comprehensive Income	(12K)	(413K)	(966K)	(43K)	8K	8.4K

Currently Active Assets on Macroaxis

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria
HMY	Harmony Gold Mining
FSM	Fortuna Silver Mines

When determining whether Passage Bio is a strong investment it is important to analyze Passage Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Passage Bio's future performance. For an informed investment choice regarding Passage Stock, refer to the following important reports:

How To Invest In Passage

Details

Is Passage Stock a good investment?

Details

What is Passage Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.

You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Passage Bio. If investors know Passage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Passage Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.07)

Return On Assets

(0.32)

Return On Equity

(0.75)

The market value of Passage Bio is measured differently than its book value, which is the value of Passage that is recorded on the company's balance sheet. Investors also form their own opinion of Passage Bio's value that differs from its market value or its book value, called intrinsic value, which is Passage Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Passage Bio's market value can be influenced by many factors that don't directly affect Passage Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Passage Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Passage Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Passage Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Passage Historical Balance Sheet

About Passage Balance Sheet Analysis

Passage Bio Balance Sheet Chart

Total Assets

Total Current Liabilities

Passage Bio balance sheet Correlations

Passage Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Passage Bio balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets

Property Plant Equipment	- 0.97	Retained Earnings
Common Stock	- 0.95	Retained Earnings
Cash	- 0.95	Net Debt
Retained Earnings	- 0.95	Other Liab
Property Plant And Equipment Gross	- 0.94	Retained Earnings
Other Stockholder Equity	- 0.93	Retained Earnings